Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study …

AJV Mézquita, F Biavati, V Falk, H Alkadhi… - Nature Reviews …, 2023 - nature.com
The detection and characterization of coronary artery stenosis and atherosclerosis using
imaging tools are key for clinical decision-making in patients with known or suspected …

The evolving role of surgical aortic valve replacement in the era of transcatheter valvular procedures

FM Juarez-Casso, JA Crestanello - Journal of Clinical Medicine, 2023 - mdpi.com
Surgical aortic valve replacement (SAVR) has long been the standard treatment for severe
symptomatic aortic stenosis (AS). However, transcatheter aortic valve replacement (TAVR) …

Incidence, predictors, and outcomes of paravalvular regurgitation after TAVR in Sievers type 1 bicuspid aortic valves

A Zito, A Buono, A Scotti, WK Kim, T Fabris… - Cardiovascular …, 2024 - jacc.org
Background Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic
valve (BAV) stenosis is technically challenging and is burdened by an increased risk of …

主动脉瓣疾病手术治疗现状与进展

王世杰, 刘鹏, 温姝钰, 王寅, 乔韡华, 董念国 - 临床心血管病杂志, 2023 - whuhzzs.com
主动脉瓣疾病的人群患病率稳中有升, 迄今为止手术治疗是其最为有效的治疗手段.
外科主动瓣膜置换, 经导管主动脉瓣置换, 主动脉瓣修复是手术治疗方案的3 大策略 …

CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC …

A Buono, C De Biase, T Fabris, M Bellamoli… - International Journal of …, 2024 - Elsevier
Background Raphe-type bicuspid aortic valve (BAV) is a potential hostile scenario in trans-
catheter aortic valve replacement (TAVR) due to pronounced calcium burden, possibly …

Early safety and mid-term clinical outcomes of technology transfer of transcatheter aortic valve implantation in patients with severe aortic valve stenosis in Vietnam: a …

VT Nhan, NQ Khoa, N Van Duong… - The Lancet Regional …, 2024 - thelancet.com
Background This study investigated the early safety and mid-term outcomes of stepwise
implementation of transcatheter aortic valve implantation (TAVI) in Vietnamese patients with …

Transcatheter aortic valve replacement with the VenusA-Pro and VenusA-Plus systems: preliminary experience in China

J Li, Y Sun, S Luo, S Zheng, J Chen, M Fu… - Frontiers in …, 2023 - frontiersin.org
Background The outcomes of transcatheter aortic valve replacement (TAVR) employing the
second-generation retrievable VenusA-Pro and VenusA-Plus delivery systems with the self …

Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation

D Feng, J Zhao, G Niu, Y Zhang, C Wang… - International Journal of …, 2024 - Elsevier
Background We aim to compare the short and long-term outcomes for aortic stenosis (AS)
patients undergone TAVR with and without ascending aorta dilation (AAD). Methods …

Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis

A Buono, A Zito, WK Kim, T Fabris, C De Biase… - Cardiovascular …, 2024 - jacc.org
Abstract Background Balloon-expandable valves (BEVs) and self-expanding valves (SEVs)
have different features that may impact the outcomes of patients with Sievers type 1 bicuspid …

One-year outcomes after Myval implantation in patients with bicuspid aortic valve stenosis—A multicentre real-world experience

A Elkoumy, J Jose, CJ Terkelsen, H Nissen… - Journal of Clinical …, 2023 - mdpi.com
Background: Bicuspid aortic valve (BAV) affects approximately 1.5% of the general
population and is seen in nearly 50% of candidates for aortic valve replacement (AVR) …